Clinical CEST MRI studies at ultra-high B0 field (7T and 9.4T)

Zaiss, M

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Meeting Abstract

Clinical CEST MRI studies at ultra-high B0 field (7T and 9.4T)

MPS-Authors

/persons/resource/persons214560

Zaiss, M
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Resource

http://www.medmeeting.org/Upload/user/1268647/file/20181123/20181123135354_7309.pdf
(Abstract)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Zaiss, M. (2018). Clinical CEST MRI studies at ultra-high B0 field (7T and 9.4T). In 7th International Workshop on Chemical Exchange Saturation Transfer (CEST 2018) (pp. 69).

Cite as: https://hdl.handle.net/21.11116/0000-0002-B55D-A

Abstract

CEST benefits of ultra-high fields due to the better frequency separation(1,2). However, is this just a benefit for the interested MR scientist or is this also of use to address clinical questions? This can only be answered if CEST measurements of humans are performed at 7T or even 9.4T both available for human scans. While judgment
about clinical benefits require larger studies, CEST in humans at UHF brings interesting preliminary insights and strong hypothesis generation.